Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys https://t.co/urVipcU8Nj
Efectos a 7 años de la vacunación con #MenAfriVac - reducción hasta cero de la colonización faríngea de meningococo A en África https://t.co/zndHJN4WnU
#AMDclips: Seven years after serogroup A meningococcal conjugate vaccine was introduced in Burkina Faso, no meningococcal carriage due to this serogroup was seen in vaccinated or unvaccinated groups. Meningococcal isolates were characterized using WGS. htt
#AMDclips: Seven years after serogroup A meningococcal conjugate vaccine was introduced in Burkina Faso, no meningococcal carriage due to this serogroup was seen in vaccinated or unvaccinated groups. Meningococcal isolates were characterized using WGS. htt
Seven years ago, a vaccine against serogroup A meningococcal carriage, MenAfriVac, was introduced in Burkina Faso. New research in @TheLancetInfDis describes the long-term effectiveness of #MenAfriVac. Full findings here➡️https://t.co/S8K9WRi2Yz https://
RT @COMOmeningitis: After a meningitis epidemic killed 25,000 people during1996-1997 in sub-Saharan Africa, the #MenAfriVac vaccine was de…
RT @COMOmeningitis: After a meningitis epidemic killed 25,000 people during1996-1997 in sub-Saharan Africa, the #MenAfriVac vaccine was de…
After a meningitis epidemic killed 25,000 people during1996-1997 in sub-Saharan Africa, the #MenAfriVac vaccine was developed to prevent future outbreaks. A study now shows that the vaccine continues to protect people from #meningitis today. Read more: h
In the sub-Saharan meningitis belt of Africa, outbreaks of meningitis are more common than anywhere else in the world. This @TheLancet article explores meningococcal carriage: https://t.co/HiiCEdYQv5 seven years after 'MenAfriVac' vaccine was introduced t
New in @TheLancetInfDis> Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys https://t.co/Oh3EqRmX20
New Research Article: Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys https://t.co/iJM7rf6grE #meningitis